[Summary] Mainly invests in health brands, corporate equity, and health industry
Baiyang Pharmaceutical Group is a health industry group driven by technological innovation. Based on its industrialization capabilities, with asset appreciation as the core and innovative incubation as a distinctive feature, the group has established an industrial pattern that integrates the incubation of medical innovation achievements, manufacturing, and commercialized development, effectively optimizing medical scenarios through technological innovation.
Based on profound insights into clinical medical scenarios, Baiyang has built a platform for transforming scientific research achievements, collaborating with research institutions to explore source innovations grounded in basic biological research and to invest in and incubate innovations with the potential to be First-in-Class. As an industrial investor, Baiyang leverages industrial funds to focus on three major value tracks: innovative drugs, high-end medical devices, and basic research platforms. By providing resources such as funding, transformation support, and marketing promotion for innovative projects, Baiyang cultivates innovative pharmaceutical and device products with clinical application value and original, independently owned intellectual property in China.
Meanwhile, Baiyang has established a commercialization platform for innovative brands (Baiyang Pharmaceutical, stock code: 301015), which accelerates the introduction of medical innovation achievements into clinical application scenarios through professional product development, manufacturing, and brand commercialization capabilities, thereby enhancing the overall efficiency and level of medical services through technological innovation. Currently, Baiyang Pharmaceutical has several innovative Chinese medicine and chemical drug products with independent intellectual property, and has incubated multiple brand innovations in treatment areas such as bone health, liver diseases, and metabolic diseases. Its marketing network covers over 14,000 large and medium-sized hospitals and 400,000 pharmacies.
Baiyang Pharmaceutical Group will continue to adhere to the strategic path of "brand, innovation, and internationalization" to provide better medical and health products and services for the whole society.
What does Baiyang Pharmaceutical Group Co., Ltd. require? Who is Baiyang Pharmaceutical Group hiring? Baiyang Pharmaceutical Group recruitment: 医疗卫生/美容保健类占比最多占21.6%，其次是计算机/网络/技术类占21.6%. What education can get in at Baiyang Pharmaceutical Group? 本科占比最多占56.3%，其次是大专占21.6%. High education required at Baiyang Pharmaceutical Group? 硕士占12.6%，博士占2.6%. Work experience required at Baiyang Pharmaceutical Group? 1-3年占比最多占37.4%，其次是3-5年占29.5%. Where are the job locations at Baiyang Pharmaceutical Group? 北京占比最多占64.2%，其次是青岛占28.9%. Based on job postings from the past year, for reference only.
Provided by
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows
Jobui does not provide an APP. Please follow our WeChat official account.
